Published in Immunol Rev on October 01, 2007
The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog (2008) 3.79
Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity (2008) 3.24
Innate immune gene polymorphisms in tuberculosis. Infect Immun (2012) 1.89
Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (2012) 1.73
Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun (2012) 1.69
Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov Today Dis Mech (2010) 1.67
Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis (2008) 1.56
Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis (2009) 1.43
Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog (2008) 1.41
Genome scan of M. tuberculosis infection and disease in Ugandans. PLoS One (2008) 1.41
Leprosy and the human genome. Microbiol Mol Biol Rev (2010) 1.27
Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J Immunol (2012) 1.21
Genetic epidemiology of tuberculosis susceptibility: impact of study design. PLoS Pathog (2011) 1.19
Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants. PLoS Pathog (2011) 1.13
NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet (2009) 1.10
Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. Hum Immunol (2010) 1.09
Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr Opin HIV AIDS (2012) 1.05
Vitamin d receptor gene polymorphism and vitamin d plasma concentration: correlation with susceptibility to tuberculosis. Adv Pharm Bull (2014) 1.03
Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev (2014) 1.03
Glucose 6-phosphate accumulation in mycobacteria: implications for a novel F420-dependent anti-oxidant defense system. J Biol Chem (2010) 1.02
Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med Genet (2010) 0.99
Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97
Cholesterol oxidase is indispensable in the pathogenesis of Mycobacterium tuberculosis. PLoS One (2013) 0.95
The role of Syk/CARD9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections. Clin Dev Immunol (2011) 0.95
Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J Infect Dis (2012) 0.94
HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS One (2009) 0.94
microRNA-146a promotes mycobacterial survival in macrophages through suppressing nitric oxide production. Sci Rep (2016) 0.92
Tuberculosis Infection: Insight from Immunogenomics. Drug Discov Today Dis Mech (2007) 0.92
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes Immun (2011) 0.92
The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferation. PLoS One (2011) 0.90
Nitric oxide not apoptosis mediates differential killing of Mycobacterium bovis in bovine macrophages. PLoS One (2013) 0.88
Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol (2014) 0.88
Association of polymorphism +874 A/T of interferon-γ and susceptibility to the development of tuberculosis: meta-analysis. Eur J Clin Microbiol Infect Dis (2012) 0.87
Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study. BMC Res Notes (2011) 0.85
Differential arabinan capping of lipoarabinomannan modulates innate immune responses and impacts T helper cell differentiation. J Biol Chem (2012) 0.84
Meta-analysis on the associations of TLR2 gene polymorphisms with pulmonary tuberculosis susceptibility among Asian populations. PLoS One (2013) 0.83
Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study. Hum Immunol (2011) 0.83
Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population. PLoS One (2016) 0.83
HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide. Front Public Health (2015) 0.83
Genomic signatures of the haarlem lineage of Mycobacterium tuberculosis: implications of strain genetic variation in drug and vaccine development. J Clin Microbiol (2010) 0.82
Screening toll-like receptor markers to predict latent tuberculosis infection and subsequent tuberculosis disease in a Chinese population. BMC Med Genet (2015) 0.82
Mycobacterium tuberculosis strains lacking surface lipid phthiocerol dimycocerosate are susceptible to killing by an early innate host response. Infect Immun (2014) 0.82
Polymorphisms in TICAM2 and IL1B are associated with TB. Genes Immun (2014) 0.81
Monocyte signal transduction receptors in active and latent tuberculosis. Clin Dev Immunol (2013) 0.81
Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice. Immunology (2013) 0.80
Synergy between vitamin D(3) and Toll-like receptor agonists regulates human dendritic cell response during maturation. Clin Dev Immunol (2013) 0.79
Epiregulin (EREG) variation is associated with susceptibility to tuberculosis. Genes Immun (2011) 0.79
Common polymorphisms in the CD43 gene region are associated with tuberculosis disease and mortality. Am J Respir Cell Mol Biol (2015) 0.79
MCP1 SNPs and pulmonary tuberculosis in cohorts from West Africa, the USA and Argentina: lack of association or epistasis with IL12B polymorphisms. PLoS One (2012) 0.78
Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study. Drug Des Devel Ther (2015) 0.77
Genetic variation in TLR genes in Ugandan and South African populations and comparison with HapMap data. PLoS One (2012) 0.76
MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage. Genes Immun (2016) 0.76
The frequency distribution of vitamin D Receptor fok I gene polymorphism among Ugandan pulmonary TB patients. F1000Res (2016) 0.75
Examining ERBB2 as a candidate gene for susceptibility to leprosy (Hansen's disease) in Brazil. Mem Inst Oswaldo Cruz (2014) 0.75
DEFB1 gene polymorphisms and tuberculosis in a Northeastern Brazilian population. Braz J Microbiol (2016) 0.75
Human ULK1 Variation and Susceptibility to Mycobacterium tuberculosis Infection. J Infect Dis (2016) 0.75
IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation. PLoS One (2017) 0.75
TLR9 gene region polymorphisms and susceptibility to tuberculosis in Vietnam. Tuberculosis (Edinb) (2015) 0.75
The role of IL-10 in Mycobacterium avium subsp. paratuberculosis infection. Cell Commun Signal (2016) 0.75
EBP50 induces apoptosis in macrophages by upregulating nitric oxide production to eliminate intracellular Mycobacterium tuberculosis. Sci Rep (2016) 0.75
Host genome polymorphisms and tuberculosis infection: What we have to say? Egypt J Chest Dis Tuberc (2013) 0.75
Heterogeneity in tuberculosis. Nat Rev Immunol (2017) 0.75
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Innate immune recognition. Annu Rev Immunol (2001) 26.65
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med (2001) 18.25
Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med (1993) 17.01
Biologic basis for interleukin-1 in disease. Blood (1996) 16.04
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96
Immunology of tuberculosis. Annu Rev Immunol (2001) 14.26
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol (1988) 14.21
Nitric oxide and macrophage function. Annu Rev Immunol (1997) 12.77
Toll-like receptors in the induction of the innate immune response. Nature (2000) 12.23
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 10.79
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Intracellular pattern recognition receptors in the host response. Nature (2006) 8.04
Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med (2003) 7.38
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet (2000) 7.25
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A (1997) 6.99
Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell (1993) 6.99
Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol (2001) 6.92
Immune recognition. A new receptor for beta-glucans. Nature (2001) 6.54
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
CARD15 mutations in Blau syndrome. Nat Genet (2001) 5.79
An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet (1997) 5.65
Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med (2003) 5.58
Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med (1997) 5.48
Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol (2002) 5.48
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol (2001) 5.36
Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol (2006) 5.35
Nod-like proteins in immunity, inflammation and disease. Nat Immunol (2006) 5.25
Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol (2006) 4.84
Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol (1999) 4.77
The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics (1995) 4.72
Ipr1 gene mediates innate immunity to tuberculosis. Nature (2005) 4.53
Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A (1999) 4.49
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
Management of tuberculosis in the United States. N Engl J Med (2001) 4.45
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol (1993) 4.23
NLRs join TLRs as innate sensors of pathogens. Trends Immunol (2005) 4.12
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis (1993) 3.75
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA (1999) 3.51
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med (2005) 3.44
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis (2003) 3.42
Vitamin D: its role and uses in immunology. FASEB J (2001) 3.40
DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med (2003) 3.32
Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet (2002) 3.30
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29
Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol (2003) 3.09
Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol (2005) 2.97
Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis (1978) 2.94
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun (2001) 2.94
Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet (2004) 2.90
A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun (2000) 2.81
Genetics of susceptibility to human infectious disease. Nat Rev Genet (2001) 2.80
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol (2002) 2.67
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest (2004) 2.65
Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet (2001) 2.54
The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med (2005) 2.50
Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax (2000) 2.49
A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res (1997) 2.46
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol (1999) 2.44
Macrophage receptors for Mycobacterium tuberculosis. Infect Immun (1998) 2.42
Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun (1987) 2.42
The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J (2004) 2.38
A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet (2005) 2.31
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun (1999) 2.31
Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med (2000) 2.28
Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol (2004) 2.27
Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med (2003) 2.22
The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem (2005) 2.21
Interferon-gamma receptor-1 gene polymorphism in tuberculosis patients from Croatia. Scand J Immunol (2003) 2.17
Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol (2002) 2.17
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med (2005) 2.15
Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol (1998) 2.14
Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol (2000) 2.12
Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis (2003) 2.08
Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med (2003) 2.08
Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol (2004) 2.08
A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle (1985) 2.08
Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm (1997) 2.05
NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog (2005) 2.04
The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res (1996) 2.04
The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood (2006) 2.03
The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele. Infect Immun (1996) 2.02
Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis (2000) 2.00
Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res (2007) 4.92
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog (2008) 3.79
The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell (2010) 3.64
Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell (2012) 3.54
Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol (2003) 2.02
Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) (2008) 1.94
Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol (2007) 1.57
Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis (2008) 1.56
Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog (2008) 1.41
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J Infect Dis (2008) 1.34
Leprosy and the human genome. Microbiol Mol Biol Rev (2010) 1.27
Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci (2008) 1.24
Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J Immunol (2012) 1.21
Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants. PLoS Pathog (2011) 1.13
Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol (2006) 1.12
Genetic variants associated with susceptibility to Helicobacter pylori. JAMA (2013) 1.11
Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun (2003) 1.11
Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. Hum Immunol (2010) 1.09
NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella pneumophila. Eur J Immunol (2010) 1.09
The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents. Am J Respir Crit Care Med (2015) 1.08
Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol (2009) 1.07
Impaired TLR5 functionality is associated with survival in melioidosis. J Immunol (2013) 0.96
Toll-like receptor signaling in airborne Burkholderia thailandensis infection. Infect Immun (2009) 0.96
Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J Infect Dis (2005) 0.96
Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J Infect Dis (2012) 0.94
Tuberculosis Infection: Insight from Immunogenomics. Drug Discov Today Dis Mech (2007) 0.92
Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol (2010) 0.92
Human CD1a deficiency is common and genetically regulated. J Immunol (2013) 0.92
The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS One (2009) 0.90
Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol (2014) 0.85
Toll-like receptors: their roles in bacterial recognition and respiratory infections. Expert Rev Anti Infect Ther (2008) 0.82
Common polymorphisms in the CD43 gene region are associated with tuberculosis disease and mortality. Am J Respir Cell Mol Biol (2015) 0.79
Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome. Int Arch Allergy Immunol (2008) 0.78
Toll-like receptor polymorphisms are associated with increased neurosyphilis risk. Sex Transm Dis (2014) 0.78
Nucleotide-binding oligomerization domain containing-like receptor family, caspase recruitment domain (CARD) containing 4 (NLRC4) regulates intrapulmonary replication of aerosolized Legionella pneumophila. BMC Infect Dis (2013) 0.77
Genetic variation in TLR genes in Ugandan and South African populations and comparison with HapMap data. PLoS One (2012) 0.76
Role of oral antibiotics in treatment of breastfeeding women with chronic breast pain who fail conservative therapy. Breastfeed Med (2014) 0.75
Human susceptibility to legionnaires' disease. Methods Mol Biol (2013) 0.75